• Medzown Tackling Flaws in Clinical Trial Enrollment Ecosystem

    Clinical Research News | A startup precision medicine management company is “cracking the code” on how to make cutting-edge treatments more accessible to patients and at the same time financially sustainable for all stakeholders. The approach of 3-year-old Medzown collapses the boundaries between clinical care and clinical trials to create a unified care pathway, according to founder and CEO Jennifer Levin Carter, M.D.

    Oct 15, 2026

  • A Vision for Connecting Better Care with Better Clinical Trial Design

    Clinical Research News | The latest episode of the Scope of Things podcast shares a conversation between Michelle Snyder of McKesson and Synapticure CEO Sandra Abravaya as they follow Abravaya’s path from public service to healthcare entrepreneurship, grounded in an ALS caregiver’s view of what happens when guidance is unavailable at the moment it matters most.

    Oct 13, 2026

  • Lab-Grown Brain Models Could Bring ‘Clinical Trials in a Vial,’ Harvard Researcher Says

    Clinical Research NewsBrain organoids, three-dimensional tissues grown from stem cells, are edging closer to the clinic, with researchers envisioning a future in which a patient's response to a drug can be tested in a lab dish before they ever enroll in a study.

    Oct 8, 2026

  • Lab-Grown Brain Models Could Bring ‘Clinical Trials in a Vial,’ Harvard Researcher Says

    Clinical Research News | Brain organoids, three-dimensional tissues grown from stem cells, are edging closer to the clinic, with researchers envisioning a future in which a patient's response to a drug can be tested in a lab dish before they ever enroll in a study.

    Oct 8, 2026

  • The Evolution of RBQM: From Regulatory Compliance to Proven ROI and Data Quality

    Clinical Research NewsToday, RBQM offers not just regulatory compliance but the ability to add measurable value to drug development and sponsor organizations. However, many organizations are still operating with fragmented tools, static risk registers and reactive monitoring models. To unlock the true power of RBQM, the industry needs to embrace its potential as a live, operational oversight model.

    Oct 6, 2026

  • The Evolution of RBQM: From Regulatory Compliance to Proven ROI and Data Quality

    Clinical Research News | Today, RBQM offers not just regulatory compliance but the ability to add measurable value to drug development and sponsor organizations. However, many organizations are still operating with fragmented tools, static risk registers and reactive monitoring models. To unlock the true power of RBQM, the industry needs to embrace its potential as a live, operational oversight model.

    Oct 6, 2026